Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2010 2
2011 1
2015 1
2016 1
2017 7
2018 1
2019 2
2020 5
2021 3
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.
Nagasaka M, Miyajima C, Inoue Y, Hashiguchi S, Suzuki Y, Morishita D, Aoki H, Toriuchi K, Katayama R, Aoyama M, Hayashi H. Nagasaka M, et al. Among authors: morishita d. Biochem Biophys Res Commun. 2024 May 14;708:149789. doi: 10.1016/j.bbrc.2024.149789. Epub 2024 Mar 16. Biochem Biophys Res Commun. 2024. PMID: 38513475
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients.
Yoshimoto T, Oshima T, Fukada T, Imamura N, Nakanishi T, Ebisutani N, Morishita D, Mieno M, Nakai K, Sei H, Kitayama Y, Eda H, Okugawa T, Tomita T, Fukui H, Shinzaki S. Yoshimoto T, et al. Among authors: morishita d. Int J Clin Oncol. 2024 Feb;29(2):142-148. doi: 10.1007/s10147-023-02438-3. Epub 2023 Dec 8. Int J Clin Oncol. 2024. PMID: 38063978
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradation.
Tokugawa M, Inoue Y, Aoki H, Miyajima C, Ishiuchi K, Tsurumi K, Kujirai C, Morishita D, Matsuno M, Mizukami H, Ri M, Iida S, Makino T, Aoyama M, Hayashi H. Tokugawa M, et al. Among authors: morishita d. J Biochem. 2024 Mar 4;175(3):253-263. doi: 10.1093/jb/mvad085. J Biochem. 2024. PMID: 37948630
Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.
Tomita T, Fukui H, Morishita D, Maeda A, Makizaki Y, Tanaka Y, Ohno H, Oshima T, Miwa H. Tomita T, et al. Among authors: morishita d. J Neurogastroenterol Motil. 2023 Jan 30;29(1):102-112. doi: 10.5056/jnm22027. J Neurogastroenterol Motil. 2023. PMID: 36606441 Free PMC article.
Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Tomita T, Fukui H, Morishita D, Mori S, Oshima T, Shinzaki S, Miwa H. Tomita T, et al. Among authors: morishita d. J Clin Med. 2022 Nov 22;11(23):6882. doi: 10.3390/jcm11236882. J Clin Med. 2022. PMID: 36498457 Free PMC article.
Insights into Regulators of p53 Acetylation.
Nagasaka M, Miyajima C, Aoki H, Aoyama M, Morishita D, Inoue Y, Hayashi H. Nagasaka M, et al. Among authors: morishita d. Cells. 2022 Nov 29;11(23):3825. doi: 10.3390/cells11233825. Cells. 2022. PMID: 36497084 Free PMC article. Review.
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
Kameda T, Shide K, Kamiunten A, Kogure Y, Morishita D, Koya J, Tahira Y, Akizuki K, Yokomizo-Nakano T, Kubota S, Marutsuka K, Sekine M, Hidaka T, Kubuki Y, Kitai Y, Matsuda T, Yoda A, Ohshima T, Sugiyama M, Sashida G, Kataoka K, Ogawa S, Shimoda K. Kameda T, et al. Among authors: morishita d. Commun Biol. 2022 Nov 29;5(1):1309. doi: 10.1038/s42003-022-04284-x. Commun Biol. 2022. PMID: 36446869 Free PMC article.
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Takeda J, Yoshida K, Nakagawa MM, Nannya Y, Yoda A, Saiki R, Ochi Y, Zhao L, Okuda R, Qi X, Mori T, Kon A, Chiba K, Tanaka H, Shiraishi Y, Kuo MC, Kerr CM, Nagata Y, Morishita D, Hiramoto N, Hangaishi A, Nakazawa H, Ishiyama K, Miyano S, Chiba S, Miyazaki Y, Kitano T, Usuki K, Sezaki N, Tsurumi H, Miyawaki S, Maciejewski JP, Ishikawa T, Ohyashiki K, Ganser A, Heuser M, Thol F, Shih LY, Takaori-Kondo A, Makishima H, Ogawa S. Takeda J, et al. Among authors: morishita d. Blood Cancer Discov. 2022 Sep 6;3(5):410-427. doi: 10.1158/2643-3230.BCD-21-0192. Blood Cancer Discov. 2022. PMID: 35839275 Free PMC article.
37 results